BG101067A - Sterol derivatives used for meiosis regulation - Google Patents

Sterol derivatives used for meiosis regulation

Info

Publication number
BG101067A
BG101067A BG101067A BG10106796A BG101067A BG 101067 A BG101067 A BG 101067A BG 101067 A BG101067 A BG 101067A BG 10106796 A BG10106796 A BG 10106796A BG 101067 A BG101067 A BG 101067A
Authority
BG
Bulgaria
Prior art keywords
sterol derivatives
derivatives used
meiosis
regulation
sterols
Prior art date
Application number
BG101067A
Other languages
Bulgarian (bg)
English (en)
Inventor
Anne BYSKOV
Claus Andersen
Lars Nordholm
Henning Thogersen
Ole Wassmann
Ivan Diers
Erling Guddal
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of BG101067A publication Critical patent/BG101067A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
BG101067A 1994-06-23 1996-12-18 Sterol derivatives used for meiosis regulation BG101067A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis

Publications (1)

Publication Number Publication Date
BG101067A true BG101067A (en) 1997-08-29

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101067A BG101067A (en) 1994-06-23 1996-12-18 Sterol derivatives used for meiosis regulation

Country Status (26)

Country Link
US (1) US5716777A (ja)
EP (1) EP0767798B1 (ja)
JP (1) JP3987105B2 (ja)
KR (1) KR100408369B1 (ja)
CN (1) CN1068333C (ja)
AT (1) ATE248852T1 (ja)
AU (1) AU694240B2 (ja)
BG (1) BG101067A (ja)
BR (1) BR9508074A (ja)
CA (1) CA2192941C (ja)
CZ (1) CZ289407B6 (ja)
DE (1) DE69531682T2 (ja)
DK (1) DK0767798T3 (ja)
ES (1) ES2204955T3 (ja)
FI (1) FI117159B (ja)
HU (1) HUT76343A (ja)
IL (1) IL114294A (ja)
IS (1) IS4404A (ja)
MX (1) MX9700174A (ja)
NO (1) NO314534B1 (ja)
PL (1) PL186688B1 (ja)
RU (1) RU2194510C2 (ja)
SI (1) SI9520077A (ja)
SK (1) SK165596A3 (ja)
UA (1) UA51622C2 (ja)
WO (1) WO1996000235A1 (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ279797A3 (cs) * 1995-03-06 1998-01-14 Novo Nordisk A/S Způsob stimulace miózy zárodečné buňky a použití sloučeniny, která způsobuje akumulaci látky aktivující endogenní miózu
BR9608968A (pt) * 1995-06-23 1999-06-29 Novo Nordisk As Composto e processo para regular meiose em uma célula germinativa de mamífero
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
AU6122696A (en) * 1995-06-23 1997-01-22 Novo Nordisk A/S Meiosis regulating compounds
JP2001506656A (ja) 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
CN1260802A (zh) * 1997-05-16 2000-07-19 阿克佐诺贝尔公司 20－芳烷基－5α－孕甾烷衍生物
CA2289524A1 (en) * 1997-06-04 1998-12-10 Akzo Nobel Nv 17.beta.-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
DK1042353T3 (da) 1997-12-18 2002-11-04 Akzo Nobel Nv 17-beta-aryl(arylmethyl)oxy(thio)alkylandrostanderivater
CA2331962A1 (en) * 1998-05-13 1999-11-18 Novo Nordisk A/S Meiosis regulating compounds
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
JP2002516272A (ja) * 1998-05-26 2002-06-04 シエーリング アクチエンゲゼルシヤフト ｃＡＭＰを増大させる化合物を単独でまたは減数分裂を刺激する少なくとも１つの化合物との組合せ物での不妊治療
IL140216A0 (en) * 1998-06-19 2002-02-10 Novo Nordisk As Meiosis regulating compounds
EP1137660B1 (en) * 1998-12-11 2002-10-02 Akzo Nobel N.V. 22s-hydroxycholesta-8,14-diene derivatives with meiosis regulating activity
WO2000036132A1 (en) 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
BR0008065A (pt) * 1999-02-10 2001-11-06 Schering Aktiengellschaft Derivados de colestano insaturados e seu uso para a preparação de medicamentos que regulam meiose
EP1156822B1 (en) * 1999-02-24 2006-02-08 Novo Nordisk A/S Iin vitro method for synchronisation of oocyte maturation
EP1156821B1 (en) * 1999-02-24 2007-05-02 Novo Nordisk A/S Treatment of infertility
CN1341147A (zh) * 1999-02-26 2002-03-20 诺沃挪第克公司 减数分裂活化甾醇增大着床率
AU3285000A (en) * 1999-03-09 2000-09-28 Akzo Nobel N.V. 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
IL148234A0 (en) * 1999-09-16 2002-09-12 Novo Nordisk As Composition for ivf
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
WO2001088098A2 (en) * 2000-05-18 2001-11-22 Schering Aktiengesellschaft Fertilization of aged oocytes
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
AU2003203145A1 (en) * 2002-02-22 2003-09-09 Novo Nordisk A/S A transducer of mas signalling
WO2012044817A2 (en) * 2010-10-01 2012-04-05 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
PL317830A1 (en) 1997-04-28
DE69531682T2 (de) 2004-07-15
FI965144A (fi) 1997-02-20
IL114294A (en) 2002-09-12
DE69531682D1 (de) 2003-10-09
ATE248852T1 (de) 2003-09-15
RU2194510C2 (ru) 2002-12-20
IS4404A (is) 1996-12-23
CZ372596A3 (en) 1997-07-16
CA2192941C (en) 2009-04-14
AU694240B2 (en) 1998-07-16
CA2192941A1 (en) 1996-01-04
BR9508074A (pt) 1997-08-12
CN1151164A (zh) 1997-06-04
JP3987105B2 (ja) 2007-10-03
EP0767798A1 (en) 1997-04-16
MX9700174A (es) 1997-04-30
CZ289407B6 (cs) 2002-01-16
HUT76343A (en) 1997-08-28
SI9520077A (sl) 1998-06-30
UA51622C2 (uk) 2002-12-16
AU2734395A (en) 1996-01-19
NO965516D0 (no) 1996-12-20
KR100408369B1 (ko) 2004-04-28
DK0767798T3 (da) 2003-12-22
JPH10502060A (ja) 1998-02-24
IL114294A0 (en) 1995-10-31
WO1996000235A1 (en) 1996-01-04
SK165596A3 (en) 1997-08-06
HU9603584D0 (en) 1997-02-28
ES2204955T3 (es) 2004-05-01
NO314534B1 (no) 2003-04-07
PL186688B1 (pl) 2004-02-27
FI117159B (fi) 2006-07-14
FI965144A0 (fi) 1996-12-20
CN1068333C (zh) 2001-07-11
NO965516L (no) 1997-02-21
EP0767798B1 (en) 2003-09-03
US5716777A (en) 1998-02-10

Similar Documents

Publication Publication Date Title
BG101067A (en) Sterol derivatives used for meiosis regulation
AU7878998A (en) Meiosis regulating compounds
IL124459A0 (en) Antagonists of gonadotropin releasing hormone
GEP20012530B (en) Neuroactive Steroids of the Androstane and Pregnane Series
IL124411A0 (en) Lipopolyamines as transfection agents and pharmaceutical uses thereof
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
DE69533991D1 (de) Dipeptide, die die ausschüttung von wachstumshormonen stimulieren
LV12438A (en) Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof
PL309225A1 (en) Pharmacologically active derivatives of pyridine and methods of obtaining them
UA39934C2 (uk) Спосіб контрацепції у осіб жіночої статі
AU4363296A (en) Methods and compositions for stimulating tissue growth and epithelial moisturization
MY115211A (en) Novel amino acid derivatives, their preparation and use
NZ300942A (en) 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists
ZA9510295B (en) Novel dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals
PL314840A1 (en) N-substituted derivatives of azabicycloheptane
PL344155A1 (en) Meiosis regulating compounds
MX9800123A (es) Compuestos que regulan la meiosis.
PL311296A1 (en) Derivatives of benzo [f] quinoxalinodione, method of obtaining them and their application in therapeutic agents
BG102238A (en) New imidazoline-2,4-dions of anticonvulsion effect containing, in the first place, orthosubstituted ar(alk)yl radical, and method for their preparation
AU6829396A (en) Compositions and their uses
MY129421A (en) INHIBITORS OF p38